Interaction with amyloid β peptide compromises the lipid binding function of apolipoprotein E

Biochemistry

Volumn 47, Issue 18, 2008, Pages 5225-5234

  Tamamizu Kato, Shiori ^a   Cohen, Jenny K ^a   Drake, Carolyn B ^a   Kosaraju, Malathi G ^a   Drury, Jessica ^a   Narayanaswami, Vasanthy ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; FLUORESCENCE; LIPIDS; MOLECULAR INTERACTIONS; OLIGOMERS; PROTEIN FOLDING;

APOLIPOPROTEIN (APO); C-TERMINAL DOMAIN (CT); LIPID BINDING FUNCTION; PROTEIN MISFOLDING;

PEPTIDES;

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; CYSTEINE; FLUORESCENT DYE;

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENERGY TRANSFER; FLUORESCENCE RESONANCE ENERGY TRANSFER; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING;

EID: 42949168275     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi702097s     Document Type: Article

References (67)

1. Raffai, R. L., and Weisgraber, K. H. (2003) Cholesterol: From heart attacks to Alzheimer's disease. J. Lipid Res. 44, 1423-1430.
2. Wetterau, J. R., Aggerbeck, L. P., Rall, S. C., Jr., and Weisgraber, K. H. (1988) Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. J. Biol. Chem. 263, 6240-6248.
3. Weisgraber, K. H. (1994) Apolipoprotein E: Structure-function relationships. Adv. Protein Chem. 45, 249-302.
4. Saito, H., Lund-Katz, S., and Phillips, M. C. (2004) Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins. Prog. Lipid Res. 43, 350-380.
5. Mauch, D. H., Nagler, K., Schumacher, S., Goritz, C., Muller, E. C., Otto, A., and Pfrieger, F. W. (2001) CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354-1357.
6. Segrest, J. P., Jones, M. K., De Loof, H., Brouillette, C. G., Venkatachalapathi, Y. V., and Anantharamaiah, G. M. (1992) The amphipathic helix in the exchangeable apolipoproteins: A review of secondary structure and function. J. Lipid Res. 33, 141-166.
7. Rensink, A. A., de Waal, R. M., Kremer, B., and Verbeek, M. M. (2003) Pathogenesis of cerebral amyloid angiopathy. Brain Res. 43, 207-223.
8. Selkoe, D. J. (1998) The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8, 447-453.
9. Naslund, J., Haroutunian, V., Mohs, R., Davis, K. L., Davies, P., Greengard, P., and Buxbaum, J. D. (2000) Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. J. Am. Med. Assoc. 283, 1571-1577.
10. Kirkitadze, M. D., Bitan, G., and Teplow, D. B. (2002) Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies. J. Neurosci. Res. 69, 567-577.
11. Huang, Y., Weisgraber, K. H., Mucke, L., and Mahley, R. W. (2004) Apolipoprotein E: Diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J. Mol. Neurosci. 23, 189-204.
12. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., and Roses, A. D. (1993) Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90, 1977-1981.
13. Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., and Roses, A. D. (1993) Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90, 8098-8102.
14. Sanan, D. A., Weisgraber, K. H., Russell, S. J., Mahley, R. W., Huang, D., Saunders, A., Schmechel, D., Wisniewski, T., Frangione, B., and Roses, A. D. (1994) Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J. Clin. Invest. 94, 860-869.
15. Chan, W., Fornwald, J., Brawner, M., and Wetzel, R. (1996) Native complex formation between apolipoprotein E isoforms and the Alzheimer's disease peptide Aβ. Biochemistry 35, 7123-7130.
16. Zhou, Z., Smith, J. D., Greengard, P., and Gandy, S. (1996) Alzheimer amyloid-β peptide forms denaturant-resistant complex with type ε3 but not type ε4 isoform of native apolipoprotein E. Mol. Med. 2, 175-180.
17. Aleshkov, S., Abraham, C. R., and Zannis, V. I. (1997) Interaction of nascent apoE2, apoE3, and apoE4 isoforms expressed in mammalian cells with amyloid peptide β (1-40). Relevance to Alzheimer's disease. Biochemistry 36, 10571-10580.
18. Tokuda, T., Calero, M., Matsubara, E., Vidal, R., Kumar, A., Permanne, B., Zlokovic, B., Smith, J. D., Ladu, M. J., Rostagno, A., Frangione, B., and Ghiso, J. (2000) Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid β peptides. Biochem. J. 348, 359-365.
19. Rebeck, G. W., Harr, S. D., Strickland, D. K., and Hyman, B. T. (1995) Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the α2-macroglobulin receptor/low-density- lipoprotein receptor-related protein. Ann. Neurol. 37, 211-217.
20. LaDu, M. J., Shah, J. A., Reardon, C. A., Getz, G. S., Bu, G., Hu, J., Guo, L., and van Eldik, L. J. (2000) Apolipoprotein E receptors mediate the effects of β-amyloid on astrocyte cultures. J. Biol. Chem. 275, 33974-33980.
21. Beffert, U., Aumont, N., Dea, D., Lussier-Cacan, S., Davignon, J., and Poirier, J. (1998) β-Amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons. J. Neurochem. 70, 1458-1466.
22. Hone, E., Martins, I. J., Jeoung, M., Ji, T. H., Ganady, S. E., and Martins, R. N. (2005) Alzheimer's disease amyloid-β peptide modulates apolipoprotein E isoform specific receptor binding. J. Alzheimer's Dis. 7, 303-314.
23. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489.
24. Choy, N., Raussens, V., and Narayanaswami, V. (2003) Intermolecular coiled-coil formation in human apolipoprotein E C-terminal domain. J. Mol. Biol. 334, 527-539.
25. Narayanaswami, V., Szeto, S. S., and Ryan, R. O. (2001) Lipid association-induced N- and C-terminal domain reorganization in human apolipoprotein E3. J. Biol. Chem. 276, 37853-37860.
26. Raussens, V., Drury, J., Forte, T. M., Choy, N., Goormaghtigh, E., Ruysschaert, J. M., and Narayanaswami, V. (2005) Orientation and mode of lipid-binding interaction of human apolipoprotein E C-terminal domain. Biochem. J. 387, 747-754.
27. Dahlgren, K. N., Manelli, A. M., Stine, W. B., Jr., Baker, L. K., Krafft, G. A., and LaDu, M. J. (2002) Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 277, 32046-32053.
28. Garzon-Rodriguez, W., Sepulveda-Becerra, M., Milton, S., and Glabe, C. G. (1997) Soluble amyloid Aβ-(1-40) exists as a stable dimer at low concentrations. J. Biol. Chem. 272, 21037-21044.
29. Weers, P. M., Abdullahi, W. E., Cabrera, J. M., and Hsu, T. C. (2005) Role of buried polar residues in helix bundle stability and lipid binding of apolipophorin III: Destabilization by threonine 31. Biochemistry 44, 8810-8816.
30. Tamamizu-Kato, S., Wong, J. Y., Jairam, V., Uchida, K., Raussens, V., Kato, H., Ruyssachaert, J.-M., and Narayanaswami, V. (2007) Modification by acrolein, a component of tobacco smoke and age-related oxidative stress, mediated functional impairment of human apolipoprotein E. Biochemistry 46, 8392-8400.
31. Liu, H., Scraba, D. G., and Ryan, R. O. (1993) Prevention of phospholipase-C induced aggregation of low density lipoprotein by amphipathic apolipoproteins. FEBS Lett. 316, 27-33.
32. Westerlund, J. A., and Weisgraber, K. H. (1993) Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization. J. Biol. Chem. 268, 15745-15750.
33. Pillot, T., Goethals, M., Najib, J., Labeur, C., Lins, L., Chambaz, J., Brasseur, R., Vandekerckhove, J., and Rosseneu, M. (1999) β-Amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: Relevance to Alzheimer's disease. J. Neurochem. 72, 230-237.
34. Aleshkov, S. B., Li, X., Lavrentiadou, S. N., and Zannis, V. I. (1999) Contribution of cysteine 158, the glycosylation site threonine 194, the amino- and carboxy-terminal domains of apolipoprotein E in the binding to amyloid peptide β (1-40). Biochemistry 38, 8918-8925.
35. Lins, L., Thomas-Soumarmon, A., Pillot, T., Vandekerchkhove, J., Rosseneu, M., and Brasseur, R. (1999) Molecular determinants of the interaction between the C-terminal domain of Alzheimer's β-amyloid peptide and apolipoprotein E α-helices. J. Neurochem. 73, 758-769.
36. Phu, M. J., Hawbecker, S. K., and Narayanaswami, V. (2005) Fluorescence resonance energy transfer analysis of apolipoprotein E C-terminal domain and amyloid β peptide (1-42) interaction. J. Neurosci. Res. 80, 877-886.
37. Phillips, J. C., Wriggers, W., Li, Z., Jonas, A., and Schulten, K. (1997) Predicting the structure of apolipoprotein A-I in reconstituted high-density lipoprotein disks. Biophys. J. 73, 2337-2346.
38. Weers, P. M., van der Horst, D. J., and Ryan, R. O. (2000) Interaction of locust apolipophorin III with lipoproteins and phospholipid vesicles: Effect of glycosylation. J. Lipid Res. 41, 416-423.
39. Fisher, C. A., Narayanaswami, V., and Ryan, R. O. (2000) The lipid-associated conformation of the low density lipoprotein receptor binding domain of human apolipoprotein E. J. Biol. Chem. 275, 33601-33606.
40. Lu, B., Morrow, J. A., and Weisgraber, K. H. (2000) Conformational reorganization of the four-helix bundle of human apolipoprotein E in binding to phospholipid. J. Biol. Chem. 275, 20775-20781.
41. Narayanaswami, V., Maiorano, J. N., Dhanasekaran, P., Ryan, R. O., Phillips, M. C., Lund-Katz, S., and Davidson, W. S. (2004) Helix orientation of the functional domains in apolipoprotein E in discoidal high density lipoprotein particles. J. Biol. Chem. 279, 14273-14279.
42. Drury, J., and Narayanaswami, V. (2005) Examination of lipid-bound conformation of apolipoprotein E4 by pyrene excimer fluorescence. J. Biol. Chem. 280, 14605-14610.
43. Vedhachalam, C., Narayanaswami, V., Neto, N., Forte, T. M., Phillips, M. C., Lund-Katz, S., and Bielicki, J. K. (2007) The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins. Biochemistry 46, 2583-2593.
44. Hatters, D. M., Peters-Libeu, C. A., and Weisgraber, K. H. (2006) Apolipoprotein E structure: Insights into function. Trends Biochem. Sci. 31, 445-454.
45. Narayanaswami, V., and Ryan, R. O. (2000) Molecular basis of exchangeable apolipoprotein function. Biochim. Biophys. Acta 1483, 15-36.
46. Saito, H., Dhanasekaran, P., Baldwin, F., Weisgraber, K. H., Lund-Katz, S., and Phillips, M. C. (2001) Lipid binding-induced conformational change in human apolipoprotein E. Evidence for two lipid-bound states on spherical particles. J. Biol. Chem. 276, 40949-40954.
47. Aizawa, Y., Fukatsu, R., Takamaru, Y., Tsuzuki, K., Chiba, H., Kobayashi, K., Fujii, N., and Takahata, N. (1997) Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: A possible role for apolipoprotein E in Alzheimer's disease. Brain Res. 768, 208-214.
48. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., and Klein, W. L. (1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 95, 6448-6453.
49. Walsh, D. M., Tseng, B. P., Rydel, R. E., Podlisny, M. B., and Selkoe, D. J. (2000) The oligomerization of amyloid β-protein begins intracellularly in cells derived from human brain. Biochemistry 39, 10831-10839.
50. Roher, A. E., Chaney, M. O., Kuo, Y. M., Webster, S. D., Stine, W. B., Haverkamp, L. J., Woods, A. S., Cotter, R. J., Tuohy, J. M., Krafft, G. A., Bonnell, B. S., and Emmerling, M. R. (1996) Morphology and toxicity of Aβ-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem. 271, 20631-20635.
51. Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., and Ashe, K. H. (2005) Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat. Neurosci. 8, 79-84.
52. Dong, L. M., and Weisgraber, K. H. (1996) Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J. Biol. Chem. 271, 19053-19057.
53. Hatters, D. M., Peters-Libeu, C. A., and Weisgraber, K. H. (2005) Engineering conformational destabilization into mouse apolipoprotein E. A model for a unique property of human apolipoprotein E4. J. Biol. Chem. 280, 26477-26482.
54. Zhang, W. Y., Gaynor, P. M., and Kruth, H. S. (1996) Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors. J. Biol. Chem. 271, 28641-28646.
55. Herscovitz, H., Gantz, D., Tercyak, A. M., Zannis, V. I., and Small, D. M. (1992) Expression of human apolipoprotein E but not that of apolipoprotein A-I by mouse C127 cells is associated with increased secretion of lipids in the form of vesicles and discs. J. Lipid Res. 33, 791-803.
56. Shimano, H., Fukazawa, C., Shibasaki, Y., Mori, N., Gotoda, T., Harada, K., Shimada, M., Yamada, N., Yazaki, Y., and Takaku, F. (1991) The effect of apo E secretion on lipoprotein uptake in transfected cells. Biochim. Biophys. Acta 1086, 245-254.
57. Ito, J., Zhang, L. Y., Asai, M., and Yokoyama, S. (1999) Differential generation of high-density lipoprotein by endogenous and exogenous apolipoproteins in cultured fetal rat astrocytes. J. Neurochem. 72, 2362-2369.
58. Dory, L. (1989) Synthesis and secretion of apoE in thioglycolate-elicited mouse peritoneal macrophages: Effect of cholesterol efflux. J. Lipid Res. 30, 809-816.
59. Zannis, V. I., McPherson, J., Goldberger, G., Karathanasis, S. K., and Breslow, J. L. (1984) Synthesis, intracellular processing, and signal peptide of human apolipoprotein E. J. Biol. Chem. 259, 5495-5499.
60. Fagan, A. M., Holtzman, D. M., Munson, G., Mathur, T., Schneider, D., Chang, L. K., Getz, G. S., Reardon, C. A., Lukens, J., Shah, J. A., and LaDu, M. J. (1999) Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice. J. Biol. Chem. 274, 30001-30007.
61. Huang, Y., Liu, X. Q., Wyss-Coray, T., Brecht, W. J., Sanan, D. A., and Mahley, R. W. (2001) Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc. Natl. Acad. Sci. U.S.A. 98, 8838-8843.
62. Cho, H. S., Hyman, B. T., Greenberg, S. M., and Rebeck, G. W. (2001) Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Aβ aggregation. J. Neuropathol. Exp. Neurol. 60, 342-349.
63. Marques, M. A., Tolar, M., Harmony, J. A., and Crutcher, K. A. (1996) A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity. NeuroReport 7, 2529-2532.
64. Tolar, M., Marques, M. A., Harmony, J. A., and Crutcher, K. A. (1997) Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated. J. Neurosci. 17, 5678-5686.
65. Wellnitz, S., Friedlein, A., Bonanni, C., Anquez, V., Goepfert, F., Loetscher, H., Adessi, C., and Czech, C. (2005) A 13 kDa carboxy-terminal fragment of ApoE stabilizes Aβ hexamers. J. Neurochem. 94, 1351-1360.
66. Golabek, A. A., Soto, C., Vogel, T., and Wisniewski, T. (1996) The interaction between apolipoprotein E and Alzheimer's amyloid β-peptide is dependent on β-peptide conformation. J. Biol. Chem. 271, 10602-10606.
67. Golabek, A. A., Kida, E., Walus, M., Perez, C., Wisniewski, T., and Soto, C. (2000) Sodium dodecyl sulfate-resistant complexes of Alzheimer's amyloid β-peptide with the N-terminal, receptor binding domain of apolipoprotein E. Biophys. J. 79, 1008-1015.